You Zhi Tong
Algemeen Directeur bij KINTOR PHARMACEUTICAL LIMITED
Vermogen: 5 M $ op 30-04-2024
Actieve functies van You Zhi Tong
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KINTOR PHARMACEUTICAL LIMITED | Algemeen Directeur | 24-03-2009 | - |
| Voorzitter | 24-03-2009 | - | |
| Oprichter | 24-03-2009 | - | |
Suzhou Kintor Pharmaceuticals, Inc.
 Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China. | Algemeen Directeur | - | - |
| Voorzitter | - | - | |
| Oprichter | 24-03-2009 | - |
Loopbaan van You Zhi Tong
Eerdere bekende functies van You Zhi Tong
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ANGN BIOM | Corporate Officer/Principal | - | - |
Opleiding van You Zhi Tong
| Cornell University | Doctorate Degree |
| Peking University | Graduate Degree |
Statistieken
Internationaal
| China | 4 |
| Verenigde Staten | 3 |
Operationeel
| Chief Executive Officer | 2 |
| Chairman | 2 |
| Founder | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| KINTOR PHARMACEUTICAL LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Suzhou Kintor Pharmaceuticals, Inc.
Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Suzhou Kintor Pharmaceuticals, Inc. engages in the technology research and development, technical services, transfer, and advice of drugs and reagents. The company was founded by Youzhi Tong on March 24, 2009 and is headquartered in Suzhou, China. | Health Technology |
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Beurs
- Insiders
- You Zhi Tong
- Ervaring
